A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD

NCT06359899 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Ark Biopharmaceutical Co., Ltd.